Advanced glycoxidation end products in chronic diseases—clinical chemistry and genetic background
- 5 August 2005
- journal article
- review article
- Published by Elsevier in Mutation Research
- Vol. 579 (1-2), 37-46
- https://doi.org/10.1016/j.mrfmmm.2005.03.024
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Purification and Characterization of Mouse Soluble Receptor for Advanced Glycation End Products (sRAGE)Journal of Biological Chemistry, 2004
- Protein oxidation status in patients with ankylosing spondylitisRheumatology, 2004
- Increased advanced oxidation protein products in Behcet's disease: a new activity marker?British Journal of Dermatology, 2004
- Ultrapure dialysate decreases plasma pentosidine, a marker of “carbonyl stress”American Journal of Kidney Diseases, 2004
- RAGE: A New Pleiotropic Antagonistic Gene?Annals of the New York Academy of Sciences, 2004
- Relationship of Pregnancy-Associated Plasma Protein-A to Renal Function and Dialysis ModalitiesKidney and Blood Pressure Research, 2004
- α-Oxoaldehyde metabolism and diabetic complicationsBiochemical Society Transactions, 2003
- Direct stimulatory effect of insulin-like growth factor-I on monocyte and macrophage tumor necrosis factor-alpha productionEndocrinology, 1996
- RAGE and amyloid-β peptide neurotoxicity in Alzheimer's diseaseNature, 1996
- Advanced oxidation protein products as a novel marker of oxidative stress in uremiaKidney International, 1996